Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis.

Coleman RL, Adler AI, Mentz RJ, Fudim M, Sattar N, Holman RR

Open source

DOI: 10.1186/s12933-025-02866-7
Published: 2025 Aug 23
Container: Cardiovascular diabetology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12933-025-02866-7,
  title = {Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis.},
  author = {Coleman RL and Adler AI and Mentz RJ and Fudim M and Sattar N and Holman RR},
  year = {2025},
  journal = {Cardiovascular diabetology},
  doi = {10.1186/s12933-025-02866-7},
  url = {https://doi.org/10.1186/s12933-025-02866-7}
}

RIS

TY  - JOUR
TI  - Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis.
AU  - Coleman RL
AU  - Adler AI
AU  - Mentz RJ
AU  - Fudim M
AU  - Sattar N
AU  - Holman RR
PY  - 2025
JO  - Cardiovascular diabetology
DO  - 10.1186/s12933-025-02866-7
UR  - https://doi.org/10.1186/s12933-025-02866-7
ER  -

APA

RL, C., AI, A., RJ, M., M, F., N, S., & RR, H. (2025). Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis.. Cardiovascular diabetology. https://doi.org/10.1186/s12933-025-02866-7

Source records

pubmed · retrieved 2026-09-26T13:52:08.241Z
europe-pmc · retrieved 2026-09-26T13:52:08.234Z
doaj · retrieved 2026-09-26T13:52:08.211Z